Showing results (111-120 of 273) with videos related to

Sort By:
Pageof 28
Scientific Reports|May 29, 2026
The microRNA (miRNA) signatures in different phases of the natural history of chronic hepatitis B virus infectionQiong Wang, Fahong Li, Yurong Yao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2007
Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infectionJi-Ming Zhang, Yang Xu, Xin-Yu Wang, et al.
Journal of Hepatology|March 26, 2008
Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replicationRuth Broering, Jun Wu, Zhongji Meng, et al.
Acta Biomaterialia|April 29, 2020
Genetic immunization against hepatitis B virus with calcium phosphate nanoparticles in vitro and in vivoLeonardo Rojas-Sánchez, Ejuan Zhang, Viktoriya Sokolova, et al.
Journal of Innate Immunity|July 23, 2013
Interferon-induced proteins with tetratricopeptide repeats 1 and 2 are cellular factors that limit hepatitis B virus replicationRongjuan Pei, Bo Qin, Xiaoyong Zhang, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 8, 2009
Spontaneous HBeAg seroconversion and loss of hepatitis B virus DNA after acute flare due to development of drug resistant mutants during entecavir monotherapyRi-Cheng Mao, You-Kuan Yin, Yan-Li Qin, et al.
Frontiers in Immunology|October 5, 2020
Excessive Neutrophils and Neutrophil Extracellular Traps in COVID-19Jun Wang, Qian Li, Yongmei Yin, et al.
Journal of Medical Virology|February 15, 2020
Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoVJia Liu, Xin Zheng, Qiaoxia Tong, et al.
Antiviral Research|December 29, 2022
MicroRNA-124 expression in Kupffer cells modulates liver injury by targeting IL-6/STAT3 signalingJinyu Wang, Xueyun Zhang, Jiajia Han, et al.
Journal of Medical Virology|January 19, 2006
Fatal liver failure with the emergence of hepatitis B surface antigen variants with multiple stop mutations after discontinuation of lamivudine therapyJi-Ming Zhang, Xin-Yu Wang, Yu-Xian Huang, et al.
Pageof 28